Your browser doesn't support javascript.
loading
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation.
Fielding, Ceri A; Weekes, Michael P; Nobre, Luis V; Ruckova, Eva; Wilkie, Gavin S; Paulo, Joao A; Chang, Chiwen; Suárez, Nicolás M; Davies, James A; Antrobus, Robin; Stanton, Richard J; Aicheler, Rebecca J; Nichols, Hester; Vojtesek, Borek; Trowsdale, John; Davison, Andrew J; Gygi, Steven P; Tomasec, Peter; Lehner, Paul J; Wilkinson, Gavin W G.
Afiliação
  • Fielding CA; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Weekes MP; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Nobre LV; Department of Cell Biology, Harvard Medical School, Boston, United States.
  • Ruckova E; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Wilkie GS; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Paulo JA; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
  • Chang C; Department of Cell Biology, Harvard Medical School, Boston, United States.
  • Suárez NM; Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Davies JA; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
  • Antrobus R; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Stanton RJ; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Aicheler RJ; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Nichols H; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Vojtesek B; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Trowsdale J; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Davison AJ; Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Gygi SP; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
  • Tomasec P; Department of Cell Biology, Harvard Medical School, Boston, United States.
  • Lehner PJ; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Wilkinson GW; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Elife ; 62017 02 10.
Article em En | MEDLINE | ID: mdl-28186488
ABSTRACT
The human cytomegalovirus (HCMV) US12 family consists of ten sequentially arranged genes (US12-21) with poorly characterized function. We now identify novel natural killer (NK) cell evasion functions for four members US12, US14, US18 and US20. Using a systematic multiplexed proteomics approach to quantify ~1300 cell surface and ~7200 whole cell proteins, we demonstrate that the US12 family selectively targets plasma membrane proteins and plays key roles in regulating NK ligands, adhesion molecules and cytokine receptors. US18 and US20 work in concert to suppress cell surface expression of the critical NKp30 ligand B7-H6 thus inhibiting NK cell activation. The US12 family is therefore identified as a major new hub of immune regulation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Virais / Células Matadoras Naturais / Citomegalovirus / Interações Hospedeiro-Patógeno / Fatores Imunológicos / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Virais / Células Matadoras Naturais / Citomegalovirus / Interações Hospedeiro-Patógeno / Fatores Imunológicos / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido